Pfizer Inc. (PFE) and QIAGEN Inc. (QGEN) Unit DxS Ltd Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients 2/8/2010
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Clinical Trial Data From a Phase 1/2 Clinical Trial of TH-302 at American Society of Clinical Oncology Gastrointestinal Conference 1/26/2010
More...
|
Delivering Medicine Directly Into a Tumor, Burnham Institute for Medical Research Study 12/10/2009
More...
|
Tumor-Attacking Virus Strikes With 'One-Two Punch', Ohio State University Medical Center Study 12/2/2009
More...
|
Stem Cells Alleviate Tumor Treatment Side Effects, University of California, Irvine Study 11/23/2009
More...
|
Detonating Tumor-Killer Drug in Cancers on Command, Baystate Medical Center Study Confirms Efficacy of University of Massachusetts - Amherst Researcher's System 11/18/2009
More...
|
Stem Cells Restore Cognitive Abilities Impaired By Brain Tumor Treatment, University of California, Irvine Study 11/10/2009
More...
|
Genetic 'Co-dependence' Exploited To Kill Treatment-resistant Tumor Cells, Dana-Farber Cancer Institute And Broad Institute Study 10/22/2009
More...
|
Short-term Stress Enhances Anti-tumor Activity In Mice, Stanford University School of Medicine Study Shows 9/22/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Provides Clinical Trial Update From a Complete Phase 1/2 Clinical Trial of TH-302 in Combination With Chemotherapy 9/21/2009
More...
|
Penn State University Researchers Isolates Liver Cancer Stem Cells Prior To Tumor Formation 9/18/2009
More...
|
Lasers and Nanoparticles Team Up to Target Tumor Cells, University of California, Santa Barbara Study 9/11/2009
More...
|
Sensitizing Tumor Response To Cancer Therapy By Using Naturally Active Compounds, University of Arizona Study 8/6/2009
More...
|
Researchers Effectively Treat Tumors With Use Of Nanotubes, Wake Forest University Baptist Medical Center Study 8/4/2009
More...
|
CytRx Corporation (CYTR) Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials 7/28/2009
More...
|
Calypso Medical Technologies Study Shows Potential for Improving Radiotherapy Treatment Accuracy of Deadly Pancreatic Tumors 7/27/2009
More...
|
Gene Mutation Responsible For Hereditary Neuroendocrine Tumor Discovered, University of Utah Study 7/24/2009
More...
|
Cellceutix's Cancer Drug Shows No Significant Indications of Toxicity 7/22/2009
More...
|
Trojan Horse For Ovarian Cancer: Nanoparticles Turn Immune System Soldiers Against Tumor Cells, Dartmouth Medical School Study 7/17/2009
More...
|
DACH1 A Key Protein For Tumor Suppression In ER+ Breast Cancer, Kimmel Cancer Institute Study 7/15/2009
More...
|
Tumor-Suppressor Recruits Help To Overcome A Barrier And Fix Cancer-causing Defects, University of Texas MD Anderson Cancer Center Study 7/1/2009
More...
|
Tumor Suppressor Gene In Flies May Provide Insights For Human Brain Tumors, Duke University Medical Center Study 6/23/2009
More...
|
Cancer Immunotherapy Can Use Small Numbers of Stem-Like Immune Cells to Destroy Large Tumors in Mice, National Cancer Institute Study 6/16/2009
More...
|
Hormone Therapy May Confer More Aggressive Properties To Prostate Tumors, University of Gothenburg Study 6/10/2009
More...
|
Gene Regulating Neuroblastoma Tumors Found, Virginia Commonwealth University Study 6/4/2009
More...
|
Infinity Pharmaceuticals, Inc. Reports Encouraging Clinical Data for IPI-504 at American Society of Clinical Oncology 2009 6/1/2009
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors 6/1/2009
More...
|
Biological Link Established Between Tumors And Depression, University of Chicago Study 5/19/2009
More...
|
Pioneering Technique Using Microwaves Successful In Treatment Of Liver Tumors, University of Leicester Study 5/13/2009
More...
|
Method To Neutralize Tumor Growth In Embryonic Stem Cell Therapy Discovered, Hebrew University of Jerusalem Study 5/7/2009
More...
|
Fluorescence-Guided Tumor Resection And MRI Enhancement Show Potential For Improved Outcome In Brain Tumor Surgery, Dartmouth-Hitchcock Medical Center Study 5/6/2009
More...
|
Massachusetts Institute of Technology (MIT): Targeting Tumors Using Tiny Gold Particles 5/5/2009
More...
|
Nektar Therapeutics (NKTR) NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at American Association for Cancer Research 4/22/2009
More...
|
Data Presented at American Association for Cancer Research Annual Meeting Show Anti-Tumor Activity of Peregrine Pharmaceuticals, Inc. (PPHM)'s Fully Human Anti-PS Antibody in Prostate Cancer Model 4/22/2009
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability 4/21/2009
More...
|
University of Southern California Researchers Develop New Drug To Target Tumor Cells And Blood Vessels 4/20/2009
More...
|
New Imaging Analysis Predicts Brain Tumor Survival, University of Michigan Health System Study 4/20/2009
More...
|
Infinity Pharmaceuticals, Inc. Halts Phase III RING Trial in Advanced Gastrointestinal Stromal Tumors 4/15/2009
More...
|
University of Florida: Light-Activated 'Lock' Can Control Blood Clotting, Drug Delivery 3/31/2009
More...
|
AstraZeneca PLC (AZN) Drug May Help Brain Tumors, Massachusetts General Hospital Study 3/31/2009
More...
|
Fetal Stem Cells Trigger Tumors In Ill Boy, PLoS Medicine Report 2/18/2009
More...
|
Gene Therapy Eliminates Brain Tumors Through Selective Recruitment Of Immune Cells, Cedars-Sinai Study 1/13/2009
More...
|
Molecule That Targets Brain Tumors Identified, University of California, Davis (UCD) Cancer Center Study 12/30/2008
More...
|
New Anti-tumor Gene Identified by Virginia Commonwealth University Researchers 12/17/2008
More...
|
Active Biotech AB's Cancer Project ANYARA: Combination with Established Tumor Therapies Promising 12/10/2008
More...
|
Studies Show Novel Device From NovoCure Ltd. May Enhance Chemotherapy Treatment In Brain Tumors 11/25/2008
More...
|
Misreading Of Damaged DNA May Spur Tumor Formation, Emory University School of Medicine Study 11/21/2008
More...
|
Inhibiting Protein May Keep Cancer Cells From Refueling; Lactic Acid Found To Fuel Tumors, Duke University And Université catholique de Louvain (UCL) Study 11/21/2008
More...
|
Laboratory Corporation of America Holdings (LH) Launches Tumor MGMT Gene Methylation Testing 11/19/2008
More...
|
Tiny Sacs Released By Brain Tumor Cells Carry Information That May Guide Treatment, Massachusetts General Hospital Study 11/17/2008
More...
|
University of Michigan Study Yields Clues To Why Some Tumors Spread 11/14/2008
More...
|
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc. (NVGN)'s OVATURE Trial Continue 11/13/2008
More...
|
Brain Tumour Tests Breakthrough, Glasgow's Southern General Hospital New Technique 11/7/2008
More...
|
DNA Clue To Child Brain Tumours, Cambridge University Study 11/4/2008
More...
|
Celldex Therapeutics, Inc. Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF 11/3/2008
More...
|
National Institutes of Health (NIH) Release: University of Texas Southwestern Medical Center And Indiana University School of Medicine Researchers Identify Mechanism And Possible Drug Treatment For Growth Of Nerve Tumors In Neurofibromatosis 10/31/2008
More...
|
Nanoparticles Target Multiple Cancer Genes, Shrink Tumors More Effectively, Penn State University College of Medicine Study 10/29/2008
More...
|
Enzon Pharmaceuticals, Inc. (ENZN)'s HIF-1 Alpha Antagonist Shows Antitumor Activity 10/27/2008
More...
|
Infinity Pharmaceuticals, Inc. Initiates International Phase 3 Registration Trial of IPI-504 in Patients With Refractory GIST 10/24/2008
More...
|
Ardea Biosciences, Inc. Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer Agents in Multiple Tumor Types 10/24/2008
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Presents Preclinical Data on Its Kinase Inhibitor, AP24534, Demonstrating Mechanism-Based Activity in Solid Tumors 10/24/2008
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Encouraging Additional Preliminary Findings From a Phase 1 Clinical Trial of TH-302 for Solid Tumors 10/23/2008
More...
|
Calando Pharmaceuticals, Inc. Announces Completion of IT-101 Phase 1 Clinical Study 10/23/2008
More...
|
Exelixis, Inc. (EXEL) Reports Positive Phase 1 Data for XL281 at EORTC-NCI-AACR Symposium 10/23/2008
More...
|
Exelixis, Inc. (EXEL) Reports Positive Phase 1 Data for XL228 at EORTC-NCI-AACR Symposium 10/23/2008
More...
|
ERYtech Pharma Proposes New Anticancer Vaccine Technology 10/22/2008
More...
|
Achilles Heel Of Common Childhood Tumor Identified, Harvard School of Dental Medicine, Harvard Medical School, and de Duve Institute at the Catholique University of Louvain Study 10/20/2008
More...
|
Infinity Pharmaceuticals, Inc. Initiates Phase 1 Trial of Novel Hedgehog Pathway Inhibitor, IPI-926 10/16/2008
More...
|
Ikonisys Inc. Reports Positive Results from Clinical Study Designed to Evaluate the Efficacy of Circulating Tumor Cell Detection with Ikonisys' Automated Microscope 10/14/2008
More...
|
Ludesi's 2D Gel Image Analysis Enabled Discovery of Potential Therapeutic Targets for Melanoma Tumors 10/14/2008
More...
|
Chemo Alone Effective in Treating Kids' Brain Tumors, University of Texas MD Anderson Cancer Center Study 10/13/2008
More...
|
Receptor Could Halt Blinding Diseases, Stop Tumor Growth, Preserve Neurons After Trauma, Researchers From Sainte-Justine Hospital Research Center, The Université De Montréal And The Institut National De La Santé Et De La Recherche Médicale (INSERM) In France Report 10/7/2008
More...
|
Children's National Medical Center and University of Iowa Researchers Develop Novel Anti-Tumor Vaccine 10/3/2008
More...
|
Computer Can Replace 2nd Mammogram Reader, University of Aberdeen Study 10/2/2008
More...
|
Trilogy Image-Guided Radiosurgery System Precisely Targets Tumors And Lesions Near The Spinal Cord And Other Critical Structures, Cedars-Sinai 10/2/2008
More...
|
New Approach To Gene Therapy May Shrink Brain Tumors, Prevent Their Spread, Massachusetts General Hospital Neuroscience Center Study 9/26/2008
More...
|
AVEO Pharmaceuticals, Inc. Initiates First Clinical Trial of Novel HGF Antagonist in Patients with Advanced Solid Tumors and Lymphomas 9/23/2008
More...
|
Fly Studies Reveal Immune Cell Responses To Tumor And Tissue Damage, Yale University School Of Medicine Study 9/19/2008
More...
|
Colorful Spy Tactics Track Live Cells Supporting Cancerous Tumors, University of California, San Francisco (UCSF) Study 9/17/2008
More...
|
Compugen Ltd. (CGEN) Discovers Peptide Drug Candidate for Treatment of Solid Tumor Cancers and Announces Positive In Vivo Results 9/16/2008
More...
|
University of California, San Diego (UCSD) Researchers Develop Nano-Sized "Cargo Ships" to Target and Destroy Tumors 9/12/2008
More...
|
Gold Nanoparticles Are Under Consideration For A Number Of Biomedical Applications, Such As Tumor Treatment -- Carnegie Mellon University, Hunter College, and RWTH Aachen Study 9/12/2008
More...
|
University of Pennsylvania School of Medicine Researchers Identify Natural Tumor Suppressor 9/11/2008
More...
|
Antiangiogenic Drugs Impede Chemotherapy-stimulated Tumor Recovery, University of Toronto Study 9/10/2008
More...
|
Five Prime Therapeutics, Inc. Initiates Phase I Clinical Trial of FP-1039 in Patients With Advanced Cancers 9/8/2008
More...
|
Massive Cancer Gene Search Finds Potential New Targets In Brain Tumors, Dana-Farber Cancer Institute and Broad Institute Study 9/5/2008
More...
|
New Endometrial Cancer Treatment Stops Growth Of Tumors And Kills Cancer Cells, Translational Genomics Research Institute (TGen) Study Shows 9/3/2008
More...
|
Barrow Researchers Identify A New Approach To Detect The Early Progression Of Brain Tumors 8/29/2008
More...
|
Spread of Cancer May Be Triggered Early in Disease Progression, Memorial Sloan-Kettering Cancer Center Study 8/29/2008
More...
|
Curis, Inc. (CRIS) Announces Nature Publication Elucidating a Paracrine Mechanism of Action in Hedgehog-Expressing Tumors 8/27/2008
More...
|
Drug-radiation Combo May Help Shrink Established Tumors, Journal of Experimental Medicine 8/26/2008
More...
|
Drugs To Inhibit Blood Vessel Growth Show Promise In Rat Model Of Deadly Brain Tumor, Medical College of Wisconsin Study 8/22/2008
More...
|
Anti-tumor Effects Are Enhanced By Inhibiting 2 Pathways Rather Than 1, Two Studies Journal of Clinical Investigation 8/22/2008
More...
|
Repros Therapeutics Inc. (RPRX) Announces No Tumors in First Completed Proellex Animal Carcinogenicity Study 8/21/2008
More...
|
Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors 8/19/2008
More...
|
Dual-Mode Nanoparticles Image Tumors Using MRI And PET 8/18/2008
More...
|
Helping Tumor Cells Not To Stick To The Wound During Surgical Removal, John D. Dingell VA Medical Center and Wayne State University Study 8/18/2008
More...
|
Slipping Through Cell Walls, Nanotubes Deliver High-potency Punch To Cancer Tumors In Mice 8/15/2008
More...
|
Childhood Brain Tumor Traced To Normal Stem Cells Gone Bad, Dana-Farber Cancer Institute and University of California, San Francisco (UCSF) Study 8/13/2008
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Initiates a Second Clinical Trial Evaluating TH-302 in Patients With Solid Tumors 8/12/2008
More...
|
Heavy Atoms Can Help Destroy Tumor Cells, CNRS/Université Paris 11 and CNRS/Institut Curie Study 8/11/2008
More...
|
Turned-off Cannabinoid Receptor Turns On Colorectal Tumor Growth, University of Texas M. D. Anderson Cancer Center Study 8/4/2008
More...
|
New Research Results Explain How Dormant Tumor Cells Become Active in Later Years, National Cancer Institute 8/4/2008
More...
|
Modified Salmonella Slows Tumor Growth, Burnham Institute for Medical Research Study 7/30/2008
More...
|
Nanoparticles + Light = Dead Tumor Cells, University of Virginia Study 7/30/2008
More...
|
Infinity Pharmaceuticals, Inc. Initiates Clinical Development of IPI-493, Its Oral Anti-Chaperone Agent, in Patients With Advanced Solid Tumors 7/30/2008
More...
|
Impotence Drugs Help Treat Brain Tumors in Cedars-Sinai Study 7/29/2008
More...
|
Cobra BioManufacturing (CBF.L) and Viromed Co. Extend Collaboration and Intend to Form an R&D and Commercial Supply Joint Venture 7/24/2008
More...
|
Holey Nanoparticles Create New Tumor Imaging and Therapeutic Agent in Washington University in St. Louis Study 7/23/2008
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Presents Safety and Preliminary Efficacy Data from Two Phase I Studies of Indibulin at American Association for Cancer Research Centennial Conference 7/23/2008
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Presents Encouraging Interim Results From a Phase 1 Clinical Trial of TH-302 for Solid Tumors At American Association for Cancer Research Conference On Translational Medicine 7/22/2008
More...
|
Stanford University School of Medicine Study of Dark-Skinned Mice Leads to Protein Linked to Bone Marrow Failure in Humans 7/21/2008
More...
|
Washington University in St. Louis Scientists Develop an Alternative to Chemotherapy: Nanoparticles Tackle Pediatric Brain Tumors 7/15/2008
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma 7/15/2008
More...
|
Umbilical Cord Stem Cells Transport Anti-Cancer Drugs Directly To Tumors, Kansas State University Study 7/11/2008
More...
|
Amgen (AMGN)'s (JOBS) Tumor-Starving Pill Helps Thyroid Cancer: M. D. Anderson Cancer Center Study 7/3/2008
More...
|
Oncolin Therapeutics, Inc. Announces the Discovery of a New More Effective Anti-Cancer Treatment in Experimental Brain Tumor Models 6/30/2008
More...
|
Blue Light Used to Harden Tooth Fillings Stunts Tumor Growth, Medical College of Georgia Study Finds 6/25/2008
More...
|
University of Navarra Researchers Identify 5 Genes Involved in the Metastasis of Breast Tumors to the Lung 6/23/2008
More...
|
Experimental Anti-Cancer Synthetic Molecule Targets Tumor Cell Growth and Angiogenesis, Centre National de la Recherche Scientifique Study 6/20/2008
More...
|
Cancer Drug Gleevec Linked to Muscle Damage, Data Published in New England Journal of Medicine 6/19/2008
More...
|
TransMolecular, Inc. Presents Imaging and Pharmacokinetic Analysis of 131Iodine-TM601 at Society for Nuclear Medicine Meeting 6/17/2008
More...
|
Primary Tumors Fuel Growth of Cancer Cells, Massachusetts Institute of Technology (MIT) Study Finds 6/13/2008
More...
|
Oxford University and University of Toronto Scientists Use Laser-Sensitive Drug to Seal Blood Vessels In A Flash 6/13/2008
More...
|
MethylGene Initiates Second Phase I Clinical Trial With MGCD265, A Multi-Targeted (c-Met) Kinase Inhibitor in Patients With Solid Tumors 6/12/2008
More...
|
GPC Biotech AG (GPCG.DE) Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes 6/12/2008
More...
|
HalcyGen Release: New Potential Application For Suba-Itraconazole(TM) In Oncology 6/11/2008
More...
|
Solid Tumor Cells Not Killed By Radiation And Chemotherapy Become Stronger; Duke University Researchers Say Blocking HIF1 Could be the Answer 6/10/2008
More...
|
University of Michigan Health System Prostate Finding Could Lead To Urine Test 6/10/2008
More...
|
Reata Pharmaceuticals, Inc. Contracts ApoCell, Inc. to Detect Innovative Biomarkers in a Phase II Clinical Study of RTA 402 for Diabetic Renal Disease 6/10/2008
More...
|
Repros Therapeutics Inc. (RPRX) Announces That Initial Findings for Proellex(R) Show No Gross Cancer Tumors in First Completed Animal Carcinogenicity Study 6/9/2008
More...
|
Cobra BioManufacturing (CBF.L) Announces Manufacturing Agreement with Viromed Co. for VM206RY 6/9/2008
More...
|
Access Pharmaceuticals (ACCP) Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD.; Transaction Value In Excess of $25 Million; Access Gains Second Source Manufacturing And Significant Clinical Trial Support 6/4/2008
More...
|
Semafore Pharmaceuticals, Inc. Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors 6/4/2008
More...
|
Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at American Society of Clinical Oncology Annual Meeting 6/3/2008
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Presentation of Positive TRU-016 Data at American Society of Clinical Oncology TRU-016 Produces Significant Anti-Tumor Activity and Long-Term Tumor Regression in Pre-Clinical Studies 6/3/2008
More...
|
Tumor Suppressor Genes Speed Up And Slow Down Aging In Engineered Mouse, Mayo Clinic Study 6/2/2008
More...
|
Infinity Pharmaceuticals, Inc. Announces Clinical Data Confirming Activity and Safety of IPI-504, a Novel Hsp90 Inhibitor, in Patients With Refractory GIST 6/2/2008
More...
|
Gloucester Pharmaceuticals, Inc. Announces Presentation of Romidepsin Phase 1 Data in Multiple Solid Tumors at American Society of Clinical Oncology 6/2/2008
More...
|
BiPar Sciences, Inc. Presents Initial Clinical Data of BSI-201, a Novel DNA Repair Inhibitor - Phase I Trials Demonstrate Safety and Clinical Benefit in Monotherapy and Combination Therapy - - Data Presented at the 2008 American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Poniard Pharmaceuticals, Inc. (PARD) Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer - Poster Presented at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Medarex, Inc. (MEDX) Release: Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 6/2/2008
More...
|
Ipsen and Spirogen's SJG-136 Shows Encouraging Results in the Treatment of Refractory Solid Tumours At American Society of Clinical Oncology 6/2/2008
More...
|
Exelixis, Inc. (EXEL) Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at American Society of Clinical Oncology 6/2/2008
More...
|
PharmaGap Inc. (GAP) Animal Tests Show 34% Reduction in Tumour Size and Increased Survival in Solid Tumour Tests of Two Colon Cancer Cell Lines 6/2/2008
More...
|
New MRI Technique Could Catch Cancer Early: University of Cambridge Study 5/29/2008
More...
|
Cellceutix Cancer Compound: Crunching the Numbers 5/29/2008
More...
|
EpiCept Corporation (EPCT) Announces Presentation of EPC2407 Data at 2008 American Society of Clinical Oncology Annual Meeting 5/29/2008
More...
|
Shanghai Demonstrations of Biofield Corp. (BZET) Device Lead to MOU to Form Chinese Joint Venture with Biofield's Master Licensee 5/23/2008
More...
|
SuperGen, Inc. (SUPG) to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008 5/22/2008
More...
|
Canadian Surgical Robot, Developed By Macdonald, Dettwiler and Associates Ltd And The University of Calgary, Makes History 5/21/2008
More...
|
A New Change In The Chromosome Of Patients With Esophageal Squamous Cell Carcinoma, Data Published In The World Journal of Gastroenterology. 5/21/2008
More...
|
New Pfizer Inc. (PFE) Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at American Society of Clinical Oncology 5/16/2008
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) to Present Clinical Data at American Society of Clinical Oncology on the Anti-Tumor and Safety Profile of Its Oral Investigational mTOR Inhibitor, Deforolimus 5/16/2008
More...
|
BiPar Sciences, Inc. Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting - First in Human Clinical Data Highlight Safety Profile of BSI-201 in Subjects with Advanced Solid Tumors 5/16/2008
More...
|
ThromboGenics Ltd. (THR.BR) Says Clinical Development Programmes Making Good Progress 5/13/2008
More...
|
S*Bio Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders 5/13/2008
More...
|
Diagnostic Test Targets Tumor Source; Stanford University To Study Genomics-Based Diagnostic Test For Uncertain Tumors 5/9/2008
More...
|
Researchers Target Tumors With Tiny 'Nanoworms' -- University of California, San Diego (UCSD) , University of California, Santa Barbara , and Massachusetts Institute of Technology (MIT) Study 5/7/2008
More...
|
Washington University School of Medicine in St. Louis Researchers Find Way To Make Tumor Cells Easier To Destroy 5/7/2008
More...
|
Unexpected Role: EGFR Protects Cancer Cells From Starving, University of Texas M. D. Anderson Cancer Center Study 5/7/2008
More...
|
New Anti-Hormone Drug Shrinks Uterus Tumors, National Institutes of Health (NIH) Study 5/1/2008
More...
|
New Cell Targets For Preventing Growth Of Breast And Other Tumors Identified by Lineberger Comprehensive Cancer Center Scientists 4/24/2008
More...
|
Scan Detects Oxygen Levels in Tumors, National Institutes of Health (NIH) Study 4/23/2008
More...
|
Mouse Studies Show Tumors Suppress Cells Responsible for Regulating the Immune System, National Cancer Institute Study 4/18/2008
More...
|
Nereus Pharmaceuticals, Inc. Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors 4/18/2008
More...
|
Gene That Reverses Blood Flow To Tumors Found by Western Australian Institute for Medical Research Researchers 4/17/2008
More...
|
Potential New Target For Treatment Of Solid Tumors In Children 4/17/2008
More...
|
Coserics Announces Company Formation Including Spin-Out of Phase 2 Clinical Asset From Serenex 4/17/2008
More...
|
MethylGene Initiates Phase I Clinical Trial for its Multi-Targeted (c-Met) Kinase Inhibitor, MGCD265, in Solid Tumor Cancers 4/17/2008
More...
|
Sirtris Pharmaceuticals (SIRT) Scientific Advisory Board Co-Chairs Publish First In-Vivo Data Showing SIRT1 Enzyme Can Suppress Tumor Development 4/16/2008
More...
|
Low-Molecular-Weight Heparins Inhibit Tumor Growth, Roswell Park Cancer Institute Study Shows 4/15/2008
More...
|
AVEO Pharmaceuticals, Inc.' Novel Triple VEGF Receptor Inhibitor Shows Tumor Regression in Patients with Advanced Renal Cancer; Clinical Activity and Tolerability in other Solid Tumors including Colon and Lung Cancers 4/15/2008
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Presents Data on SPI-1620, a Novel Adjunct to Chemotherapy, at the American Association for Cancer Research Meeting 4/15/2008
More...
|
Early Data on Amgen (AMGN)'s Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types 4/14/2008
More...
|
New Preclinical Data Show Significant Anti-Tumor Activity Associated With Infinity Pharmaceuticals, Inc.'s Hedgehog Antagonist IPI-926 4/14/2008
More...
|
Blood Pressure Enzyme Can Have Tumor-sensing Role, Emory University Study 4/11/2008
More...
|
New Regulatory Circuit Identified For Aggressive, Malignant Brain Tumor, Dana-Farber Cancer Institute and Memorial Sloan-Kettering Cancer Center Study 4/10/2008
More...
|
Purdue University Engineers Create Needle-size Device to Track Tumors, Radiation Dose 4/9/2008
More...
|
New Clinical Data on AVEO Pharmaceuticals, Inc.' Investigational Triple VEGFR Small Molecule Inhibitor AV-951 to be Presented at American Association for Cancer Research Annual Meeting 4/8/2008
More...
|
New Study Shows KGK Synergize's Dermytol Produces Pronounced Decrease In Malignant Melanoma Tumor Volume 4/7/2008
More...
|
EpiCept Corporation (EPCT) Announces Positive Clinical Data from EPC2407 Phase I Cancer Trial 4/7/2008
More...
|
Nano-sized Technology Has Super-Sized Effect On Tumors, Washington University School of Medicine Study 4/3/2008
More...
|
Replacing Absent MicroRNAs Could Make Tumors Less Invasive, More Treatable, University of Chicago Study 4/3/2008
More...
|
Two-photon Nanoparticles For The Improved Detection Of Tumor Cells 4/1/2008
More...
|
Special MRI Spots When Brain Tumors Turn Deadly 3/28/2008
More...
|
MRI: A Window To Genetic Properties Of Brain Tumors 3/25/2008
More...
|
Miami Doctor Breaks New Ground In Cancer Surgery 3/25/2008
More...
|
Scans Spot Hidden Tumors In Rare Cancer Syndrome, Dana-Farber Cancer Institute Study 3/21/2008
More...
|
Tumour Growth Block Hopes Raised, Harvard Medical School Study 3/18/2008
More...
|
Cell Recycling Protects Tumor Cells From Anti-Cancer Therapy, University of Tübingen Study 3/7/2008
More...
|
New Target For Cancer Therapy May Improve Treatment For Solid Tumors, University of Chicago Research 3/5/2008
More...
|
Novel Way To Develop Tumor Vaccines: Regulate Immune Inhibitor To Overcome Tumor Supression, University of Southern California Study 3/5/2008
More...
|
Blocking Protein Kills Prostate Cancer Cells, Inhibits Tumor Growth, Kimmel Cancer Institute Study 3/3/2008
More...
|
Tumor-killing Virus Selectively Targets Diseased Brain Cells 2/22/2008
More...
|
Missing Chromosome Predicts Brain Tumor Patients' Response To Treatment 2/22/2008
More...
|
New Strategy For Normalizing Tumor Blood Supply Identified 2/21/2008
More...
|
Oncoproteins Double-team And Destroy Vital Tumor-suppressor 2/19/2008
More...
|
Tumor-Targeting Viral Therapy Slows Neuroblastoma, Malignant Peripheral Nerve Sheath Tumors 2/15/2008
More...
|
Hana Biosciences, Inc. (HNAB) Announces Top-Line Phase 1 Clinical Trial Data Demonstrating Alocrest to be Well-Tolerated With Promising Anti-Tumor Activity 2/12/2008
More...
|